Literature DB >> 814005

Hyperparathyroidism in hepatobiliary disease in infancy.

A Kobayashi, S Kawai, T Utsunomiya, Y Ohbe.   

Abstract

Metabolism of calcium and magnesium may be disturbed in hepatobiliary disease because of deficient or absent bile flow into the gut, since bile is important for the intestinal absorption of these elements. In the present paper the tubular reabsorption of phosphate (TRP), calcium (TRCa), and magnesium (TRMg) were determined in an attempt to evaluate the parathyroid function of infants and children with hepatobiliary disease. In unrepaired biliary atresia TRP was conspicuously reduced (mean 49.8%, SD 15.1). In successfully repaired biliary atresia the value was increased near the normal range (mean 80.7%, SD 8.1). In neonatal hepatitis the value was variable in individual cases, but significantly lower than the normal (mean 47.6%, SD 19.9). TRCa was reduced in one third of the patients with unrepaired biliary atresia and in one fifth of the cases of neonatal hepatitis. The value was within the normal range in repaired biliary atresia. TRMg was decreased in both unrepaired and repaired biliary atresia and in neonatal hepatitis. The effect of intravenous calcium infusion on TRP, TRCa and TRMg was evaluated in 3 patients with unrepaired biliary atresia. TRP was conspicuously enhanced after infusion. TRCa was decreased in 3 to a variable extent. TRMg was moderately increased in 2 and greatly decreased in 1. These results indicate that infants with hepatobiliary disease are in a state of secondary hyperparathyroidism because of deficient or absent bile flow into the intestines.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 814005     DOI: 10.1007/BF00464390

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  39 in total

1.  Effect of aldosterone on the metabolism of magnesium.

Authors:  R HORTON; E G BIGLIERI
Journal:  J Clin Endocrinol Metab       Date:  1962-12       Impact factor: 5.958

2.  The metabolism of aldosterone in normal subjects and in patients with hepatic cirrhosis.

Authors:  W S COPPAGE; D P ISLAND; A E COONER; G W LIDDLE
Journal:  J Clin Invest       Date:  1962-08       Impact factor: 14.808

3.  Fluorometric estimation of magnesium with 8-hydroxy-5-quinolinesulfonate.

Authors:  D SCHACHTER
Journal:  J Lab Clin Med       Date:  1961-09

4.  The role of bile in calcium absorption.

Authors:  F W LENGEMANN; J W DOBBINS
Journal:  J Nutr       Date:  1958-09-10       Impact factor: 4.798

5.  Intestinal absorption of calcium and magnesium in hepatobiliary disease in infancy.

Authors:  A Kobayashi; T Utsunomiya; Y Obe; Y Nagashima
Journal:  Arch Dis Child       Date:  1974-02       Impact factor: 3.791

6.  Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate.

Authors:  L M Sherwood; G P Mayer; C F Ramberg; D S Kronfeld; G D Aurbach; J T Potts
Journal:  Endocrinology       Date:  1968-11       Impact factor: 4.736

7.  Biologically active metabolite of vitamin D3 from bone, liver, and blood serum.

Authors:  J Lund; H F DeLuca
Journal:  J Lipid Res       Date:  1966-11       Impact factor: 5.922

8.  The effect of bile, bile acids and detergents on calcium absorption in the chick.

Authors:  D D Webling; E S Holdsworth
Journal:  Biochem J       Date:  1965-11       Impact factor: 3.857

9.  Evidence for a direct action of cholecalciferol and 25-hydroxycholecalciferol on the renal transport of phosphate, sodium, and calcium.

Authors:  J B Puschett; J Moranz; W S Kurnick
Journal:  J Clin Invest       Date:  1972-02       Impact factor: 14.808

10.  47 Calcium abosrption in parenchymatous and biliary liver disease.

Authors:  M J Whelton; A K Kehayoglou; J E Agnew; L A Turnberg; S Sherlock
Journal:  Gut       Date:  1971-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.